mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmen Martinez, M; Gueguen, N; Homedan, C; Jacques, C; Laafi, J; Malthièry, Y; Puy, H; Reynier, P; Schmitt, C | 1 |
| Knox, SJ; Peehl, DM; Tian, J | 1 |
2 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and Liver Neoplasms
| Article | Year |
|---|---|
Pro-oxidant effect of ALA is implicated in mitochondrial dysfunction of HepG2 cells.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Antioxidants; Blotting, Western; Carcinoma, Hepatocellular; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electron Transport Complex I; Gene Expression; Hep G2 Cells; Humans; Ion Channels; Liver Neoplasms; Metalloporphyrins; Microscopy, Confocal; Mitochondria; Mitochondrial Proteins; Oxidants; Oxygen Consumption; Protoporphyrins; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Superoxide Dismutase; Transcription Factors; Uncoupling Protein 2 | 2014 |
Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through fenton chemistry.
Topics: Antioxidants; Apoptosis; Ascorbic Acid; Blotting, Western; Catalase; Cell Proliferation; Drug Synergism; Glutathione; Glutathione Reductase; Humans; Hydrogen Peroxide; Hydroxyl Radical; Liver Neoplasms; Male; Manganese; Membrane Potential, Mitochondrial; Metalloporphyrins; Neoplasms, Hormone-Dependent; Oxidation-Reduction; Pancreatic Neoplasms; Prostatic Neoplasms; Reactive Oxygen Species; Superoxides; Tumor Cells, Cultured | 2010 |